Note: Sample below may appear distorted but all corresponding word document files contain proper formattingExcerpt from Term Paper:
In fact, many researchers believed that free radicals, produced when the body burns oxygen to produce energy consumed in food, may be at cause. Free radicals are believed to damage brain cells by taking electrons away from the body's healthy molecules to balance themselves. A few 'free radicals' is not a problem.
IF there are too many free radicals, the 'oxidative damage' affects the brain causing AD symptoms (Healing with Nutrition Web site).
Other risk factors
Odle (2003) notes that if a person has a first-degree relative (parent, sibling) with AD, that person's relative risk of getting it is about 3.5, or that person is 3.5 times more likely than the rest of us to develop AD. When the number of first-degree relatives rises to two or more, the relative risk rises to about 7.5.
In addition, people with Down syndrome, who have an extra APP gene, which is located on the 21 chromosomes, also have an increased risk above that of the general population; it is set at about 2.5 (Odle, 2003).
Researchers also noted that less obvious risk factors exist, including hypertension (high blood pressure) which predisposes some people to AD and vascular dementia (Boustnie et al., 2003 and Kawas et al., 1999).
Another list of risk factors includes:
Lack of participation in meaningful mental activities (Shumaker 2003, Coyle 2003, Green et al. 2003).
Further, lack of education seems to double the risk of dementia in those over age 75. And traumatic events that lead to unconsciousness and/or hospitalization, as well as repeated head injuries, lead to a relative risk rating higher than 2 (Kawas 1999).
It is apparent that most current research is being done on genetic causes of AD; of course, as many researchers noted, environmental factors may cause genetic factors to 'turn on' and begin a disease process. In addition, there seems to be developing a complex of physical conditions involving genes, proteins and enzymes that is suggestive in ascertaining the likelihood that certain populations will experience AD.
Alzheimers head injury risk." Australasian Business Intelligence, 2002, Unpaged. 25 ct. 2005 http://www.highbeam.com.
Barker D, Osmond C, Simmonds S, Wield G. "The relation of small head circumference and thinness at birth to death from cardiovascular disease in later life." BMJ 306:422-426 (1993).
Bick KL. "The early story of Alzheimer disease." In: Terry, RD, Katzman R, Bick KL, Sisodia SS, eds. Alzheimer Disease. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:1-10.
Blank, Robert H. "Brain Scan: Studying the Human Brain Reveals Complex Issues. Forum for Applied Research and Public Policy, 1998;13,3:90+.
Boustani M, Peterson B, Hanson L, Harris R. Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138(11):927-937.
Causes of Alzheimers." 25 Oct. 2005. http://www.paralumun.com/alzheimercauses.htm.
Chandra V, Pandav R. Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol. Neuroepidemiology 17:225-32 (1998).
Coyle JT. Use it or lose it-do effortful mental activities protect against dementia? N. Engl J. Med. 2003;348:2489-2490.
Droller, Daniel. "Early environmental origins of neurodegenerative disease in later life. (Research / Mini-Monograph) Environmental Health Perspectives (2005, Sept. 1).
Genetics and dementia." Alzheimer's Society Information Sheet. (June 2003)
Genetics and Pathobiology of Vascular Cognitive Impairment." Environmental Health Perspectives. 2004; 112, 16: 950+.
Green RC, Cupples LA, Kurz A, et al. Depression as a risk factor for Alzheimer disease. Arch Neurol. 2003;60:753-759.
Hecht, Annabel. "Searching for Clues to Alzheimer's Disease." FDA Consumer, 1985;19:23+.
Kawas CH, Katzman R. Epidemiology of dementia and Alzheimer disease. In: Terry RD, Katzman R, Bick KL, Sisodia SS, eds. Alzheimer Disease. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:95-116.
Magnesium. Magnesium Research (1996) 9, 2, 139-141
Mayeux R, Ottman R, Maestre G, Ngai C, Tang M-X, et al. Synergistic effects of traumatic head injury and apolipoprotein-[epsilon]4 in patients with Alzheimer's disease. Neurology 45:555-57 (1995)
Odle, Teresa G. "Alzheimer disease and other dementias." Radiologic Technology; 2003, unpaged. 25 Oct. 2005 http://www.highbeam.com.
Rose, Richard J. "Genes and Human Behavior." Annual Review of Psychology. 1995; 46:625+.
Rutter, Michael and Judy Silberg. "Gene-Environment Interplay in Relation to Emotional and Behavioral DisturbanceAnnual Review of Psychology, 2002: 463+.
Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia…[continue]
"Alzheimer's Disease While Most People" (2005, October 26) Retrieved December 2, 2016, from http://www.paperdue.com/essay/alzheimer-disease-while-most-people-69905
"Alzheimer's Disease While Most People" 26 October 2005. Web.2 December. 2016. <http://www.paperdue.com/essay/alzheimer-disease-while-most-people-69905>
"Alzheimer's Disease While Most People", 26 October 2005, Accessed.2 December. 2016, http://www.paperdue.com/essay/alzheimer-disease-while-most-people-69905
Alzheimer's disease has developed into a major health concern for the elderly population throughout the world. This degenerative brain disorder was first described by Alois Alzheimer in 1907. Today Alzheimer's is one of the most prevalent forms of brain disorders contributing to as much as 50 to 70% of all reported cases of dementia. Over the years the study of early onset Alzheimer's disease (pre-senile AD) has kind of overshadowed
Alzheimer's Disease Stages of Alzheimer's and Activities for people with Dementia Stages and Symptoms of Alzheimer's Alzheimer's Stage 1: No Cognitive Impairment Alzheimer's Stage 2: Very Mild Cognitive Decline Alzheimer's Stage 3: Mild Cognitive Decline Alzheimer's Stage 4: Moderate Cognitive Decline Alzheimer's Stage 5: Moderately Severe Cognitive Decline Alzheimer's Stage 6: Severe Cognitive Decline Alzheimer's Stage 7: Very Severe Cognitive Decline Activities for people suffering from Dementia The Alzheimer's disease is a progressive, degenerative disease which affects the brain and leads
ALZHEIMER'S DISEASE Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Efforts to develop a drug for Alzheimer's disease, which mostly affect people in older age, have not been successful. Instead, most of the treatments offered often target the behavioral symptoms of the affected individual, but not the cause of the disease. The occurrence
A. Harvard Women's Health Watch (2010) Preserving and improving memory as we age. Feb 1: NA B. This is an article that is written directly to consumers who are over the age of 50 and are starting to notice changes in the ability to remember things. It addresses the fact that this wrongly causes fear in some people that they are prone toward Alzheimer's disease. Studies have shown that cognitive decline
One of the most common mental disorders linked to Alzheimer's is depression which according to Elwood Cohen manifests itself in three important ways. First, "There are higher rates of depression among Alzheimer's patients than among non-demented adults;" second, "Having a depressive episode is associated with an increased risk for developing Alzheimer's," and third, Depressive symptoms can be confused with dementia in older adults" (1999, 214). In a recent study conducted
After 13 months, the rats begin to show signs of dementia including reduced cognitive ability and memory impairment (McGill University, 2010). Amyloid B. immunotherapy Past research Past research on the effects of active or passive a? immunization on a? buildup and AD progression provided evidence that such immunization "protects against the progressive loss of synaptophysin in the hippocampal molecular layer and frontal neocortex of a transgenic mouse model of AD" (Buttini &
Scientists are racing to find a cure as millions of people reach the age when Alzheimer's is most commonly manifested (Plontz). Experts are still trying to fully understand the cause or causes of Alzheimer's disease. In the meantime, it's helpful to understand the hallmarks of Alzheimer's -- plaques and tangles -- and the risk factors that affect a person's likelihood of developing the disease (Hill). Alzheimer's disease is characterized by a